Edwards Lifesciences Financial Leverage Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 141.34  1.94  1.39%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Financial Leverage of Edwards Lifesciences Corporation with missing and latest data points interpolated. Interest burden is a component of DuPont return on equity analysis calculated by dividing Earnings before Tax by Earning Before Interest and Taxes EBIT . This will be 1 for a company with no Interest Expense.
Financial Leverage  10 Years Trend  
Slightly volatile
 Financial Leverage 

Edwards Lifesciences Financial Leverage Over Time

2016-12-31  0.97 
2017-12-31  0.97 
2018-12-31  1.14 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  0.98
Geometric Mean  0.98
Coefficient Of Variation  6.74
Mean Deviation  0.034112
Median  0.98
Standard Deviation  0.065961
Sample Variance  0.004351
Range  0.32
R Value  0.66
Mean Square Error  0.002689
R Squared  0.43
Significance  0.014428
Slope  0.01115
Total Sum of Squares  0.05221

Currently Trending

Sold over 70 shares of
1 hour ago ago
Traded for 37.94
Purchased over 40 shares of
1 hour ago ago
Traded for 61.5945
Sold over 200 shares of
1 hour ago ago
Traded for 11.15